News Column

Zhejiang Medicine H1 Net Down 40%

August 13, 2014

ZHEJIANG, August 13, SinoCast -- Zhejiang Medicine Co., Ltd. (SHSE: 600216) revealed operating revenue of CNY 2.544 billion in the first half of 2014, narrowing 2.8% from a year earlier. Net profit attributable to shareholders reached CNY 212 million, declining 40.8%. Basic EPS were CNY 0.23.

Major products of the company vitamins have recorded rising sales volume but negative price factors.

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Sinocast Health Care & Medicine Beat (China)

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters